National Health Research Institutes:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:National Health Research Institutes - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9310
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Health Research Institutes (NHRI) is a non-profit foundation that performs medical research programs. The foundation investigates various aspects of basic biomedical sciences and diseases including aging, cancer, infectious diseases, mental disorders and occupational diseases. It conducts research programs in the areas of cancer, cellular and systems medicine, aging related musculoskeletal diseases, population health sciences, regenerative medicine, molecular and genomic medicine, infectious diseases and vaccinology, medical engineering, and others. NHRI plans the overall direction of national science and technology development in health and medical care. The foundation also coordinates, integrates, and supports research activities undertaken by medical institutions. It operates with an additional office in Taipei. NHRI is headquartered in Zhunan, Taiwan.

National Health Research Institutes – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Health Research Institutes, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
National Health Research Institutes, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Molecular Targeting Enters into Co-Development Agreement with National Health Research Institutes 10
Licensing Agreements 11
HuniLife Biotech Enters into Licensing Agreement with DCB and NHRI 11
Medigen Vaccine Biologics Enteres into Licensing Agreement with National Health Research Institutes 12
Adimmune Enters into Licensing Agreement with National Health Research 13
Microbio Enters into Licensing Agreement with National Health Research Institutes 14
Asset Transactions 15
Genovate Biotech Acquires China Rights to DBPR108 from National Health Research Institutes 15
National Health Research Institutes – Key Employees 16
National Health Research Institutes – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Product News 18
12/21/2017: Sundia Congratulates NHRI for DBPR114 IND Approval in US & Taiwan 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
National Health Research Institutes, Pharmaceuticals & Healthcare, Key Facts 2
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Health Research Institutes, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Health Research Institutes, Deals By Therapy Area, 2012 to YTD 2018 8
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Molecular Targeting Enters into Co-Development Agreement with National Health Research Institutes 10
HuniLife Biotech Enters into Licensing Agreement with DCB and NHRI 11
Medigen Vaccine Biologics Enteres into Licensing Agreement with National Health Research Institutes 12
Adimmune Enters into Licensing Agreement with National Health Research 13
Microbio Enters into Licensing Agreement with National Health Research Institutes 14
Genovate Biotech Acquires China Rights to DBPR108 from National Health Research Institutes 15
National Health Research Institutes, Key Employees 16
National Health Research Institutes, Other Locations 17

List of Figures
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[National Health Research Institutes:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Punj Lloyd Ltd (PUNJLLOYD):企業の財務・戦略的SWOT分析
    Punj Lloyd Ltd (PUNJLLOYD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Philips Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Philips Healthcare, formerly Philips Medical Systems, undertakes the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlan …
  • Global Telecom Holding S.A.E.:企業の戦略・SWOT・財務分析
    Global Telecom Holding S.A.E. - Strategy, SWOT and Corporate Finance Report Summary Global Telecom Holding S.A.E. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Air Liquide SA (AI)-エネルギー分野:企業M&A・提携分析
    Summary Air Liquide SA (Air Liquide) is a provider of gases, technologies and services for industry and health. The company produces core air gases such as oxygen, nitrogen, and hydrogen along with argon and other rare gases. It supplies gases to customers in multiple industries, including steel, ch …
  • Lumosa Therapeutics Co Ltd (6535):製薬・医療:M&Aディール及び事業提携情報
    Summary Lumosa Therapeutics Co Ltd (Lumosa Therapeutics) is a developer of drugs for the treatment of neurological and inflammatory diseases. The company’s pipeline products include LT-1001, an analgesic injection for severe pain relief; and LT-3001, a novel small molecule for acute ischemic stroke. …
  • Bausch & Lomb Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, …
  • KBI Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary KBI Biopharma Inc (KBI) a subsidiary of JSR Corp is a biopharmaceutical contract development and manufacturing organization that develops novel discoveries into life changing biological products. The organization’s service portfolio includes process development and cGMP manufacturing of reco …
  • Piraeus Bank SA:企業の戦略・SWOT・財務情報
    Piraeus Bank SA - Strategy, SWOT and Corporate Finance Report Summary Piraeus Bank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Mitralign Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mitralign Inc (Mitralign) is a medical device company that offers direct transcatheter annuloplasty system to treat both functional tricuspid regurgitation and mitral regurgitation. The company’s products include crossing wire, pledget delivery catheter and placation lock delivery catheter, …
  • KBC Group NV:企業のM&A・事業提携・投資動向
    KBC Group NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KBC Group NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Quark Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Quark Pharmaceuticals Inc (Quark), a subsidiary of SBI Biotech Co Ltd, is a clinical-stage pharmaceutical company in the development of novel RNAi-based therapeutics. It offers under development products which include PF-655, a synthetic siRNA which is used for the treatment of diabetic macu …
  • Fagron NV (FAGR)-医療機器分野:企業M&A・提携分析
    Summary Fagron NV (Fagron), formerly Arseus NV is a provider of pharmaceutical compounding solutions. The company provides compounding essentials, trademarks, and pharma services to pharmacies, hospitals and clinics. Its compounding services provide customized pharmaceutical products for specific pa …
  • Pascal Biosciences Inc (PAS):製薬・医療:M&Aディール及び事業提携情報
    Summary Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biotechnology company that discovers and develops treatments in the field of immuno-oncology. The company develops targeted agents that enable the body's own immune system to recognize and attack cancers, in …
  • Maxion Wheels Inc:企業の戦略的SWOT分析
    Maxion Wheels Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • GEDI Gruppo Editoriale SpA (GEDI):企業の財務・戦略的SWOT分析
    GEDI Gruppo Editoriale SpA (GEDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • China Agri-Industries Holdings Ltd (606):企業の財務・戦略的SWOT分析
    China Agri-Industries Holdings Ltd (606) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Globe Specialty Metals, Inc.:企業の戦略・SWOT・財務情報
    Globe Specialty Metals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Globe Specialty Metals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Kedrion SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The company’s products are used for the treatment of rare and serious disorders such as hemophilia, immune deficiency and neurological disorders. It also offers products …
  • bioMerieux SA (BIM):企業の財務・戦略的SWOT分析
    bioMerieux SA (BIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Airgas, Inc.:戦略・SWOT・企業財務分析
    Airgas, Inc. - Strategy, SWOT and Corporate Finance Report Summary Airgas, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆